<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">
	<head>
		<meta charset="utf-8" />
		<title>BCSC1718_S04_C03_p025_032</title>
		<link href="BCSC1718_S04_C03_p025_032-web-resources/css/idGeneratedStyles.css" rel="stylesheet" type="text/css" />
	</head>
	<body id="BCSC1718_S04_C03_p025_032" lang="en-US">
		<div id="_idContainer002" class="Basic-Text-Frame">
			<p class="chapter-number"><span class="cn-chap">Chapter </span>3</p>
			<p class="chapter-title">Specimen Handling</p>
			<p class="video-list-mid ParaOverride-2"><img class="_idGenObjectAttribute-1" src="data:image/png;base64,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" alt="" />&#9;This chapter includes related videos, which can be accessed by scanning the QR codes provided in the text or going to www.aao.org/bcscvideo_section04.</p>
			<p class="h1 ParaOverride-3">Communication</p>
			<div id="Chapt3_Top1">
			<p class="body-text--no-indent-">Communication with the pathologist before, during, and after surgical procedures is an essential aspect of quality patient care. Standards for the technical handling of specimens and reporting of results have been developed; a few are available online at no cost. The ophthalmologist should provide a relevant and reasonably detailed clinical history when submitting the specimen to the laboratory. This history facilitates clinicopathologic correlation and enables the pathologist to provide the most accurate interpretation of the specimen. The final histologic diagnosis reflects successful collaborative work between clinician and pathologist.</p>
			<p class="body-text">If the pathologist and the ophthalmologist have an ongoing relationship, communication can usually be accomplished via the pathology request form and the pathology report. However, if malignancy is suspected or if the biopsy will be used to establish a critical diagnosis, direct and personal preoperative communication between the surgeon and the pathologist can be essential. This consultation allows the physicians to discuss the best way to submit a specimen. For example, the pathologist may wish to have fresh tissue for immunofluorescence staining and molecular diagnostic studies, glutaraldehyde-&#173;fixed tissue for electron microscopy, and formalin-&#173;fixed tissue for routine paraffin embedding. If the tissue is simply submitted in formalin, the opportunity to perform certain studies may be lost, resulting in a less definitive diagnosis. Communication between clinician and pathologist is especially important in ophthalmic pathology, in which specimens are often very small and require very careful handling. In some cases, careful selection of the surgical facility is necessary to ensure proper specimen handling. See Chapter&#160;4, Table&#160;4-1, for a preoperative checklist addressing the handling of ophthalmic pathology specimens.</p>
			<p class="body-text">Anytime a previous biopsy has been performed at the site of the present pathology, the clinician should request the sections of the previous biopsy and review them with the pathologist who will interpret the second biopsy. The surgical plan may be altered substantially if the initial biopsy was thought to represent, for example, a basal cell carcinoma when in fact the disease was a sebaceous carcinoma. In addition, when the case has been reviewed in advance, the pathologist will be able to interpret intraoperative frozen sections more accurately.</p>
			<p class="body-text">If substantial disagreement arises between the clinical diagnosis and the histologic diagnosis, the ophthalmologist should promptly contact the pathologist directly to resolve the discrepancy. For example, merely correcting the patient age on the pathology request form may change the interpretation of melanotic lesions of the conjunctiva from benign to malignant, or vice versa.</p>
			<p class="reference-first">College of American Pathologists. Cancer protocol templates. www.cap.org/web/home<br />/resources/cancer-reporting-tools/cancer-protocol-templates. Accessed March 7, 2016.</p>
			<p class="reference-last ParaOverride-4">Jain D, Pernick N. Eye. PathologyOutlines.com. www.pathologyoutlines.com/eye.html. Accessed March 7, 2016.</p>
			</div>
			<p class="h1 ParaOverride-5">Fixatives for Tissue Preservation</p>
				<div id="Chapt3_Top2">
			<p class="body-text--no-indent-">The most commonly used fixative is 10% neutral-&#173;buffered formalin. Formalin is a 40% solution of formaldehyde that stabilizes proteins, lipids, and carbohydrates and prevents enzymatic destruction of the tissue (autolysis). In specific instances, other fixatives may be preferred, such as glutaraldehyde for electron microscopy, ethyl alcohol for cytologic preparations, and Michel medium for immunofluorescence studies. <span class="xref-table">Table&#160;3-1</span> lists examples of commonly used fixatives.</p>
			<p class="body-text">Formalin diffuses rather quickly through tissue. Because most of the functional tissue of the eye is located within 2–3&#160;mm of the surface, it is not necessary or desirable to open the eye. Opening an eye before fixation may damage or distort sites of pathology, making histologic interpretation difficult or impossible. It is generally desirable to suspend an eye in formalin in a volume of approximately 10:1 for at least 24–48&#160;hours prior to processing to ensure adequate fixation. However, different institutions may use different protocols, so preoperative consultation is critical.</p>
			</div>
			<p class="h1">Orientation</p>
				<div id="Chapt3_Top3">
			<p class="body-text--no-indent-">Globes may be oriented according to the location of the extraocular muscles and of the long posterior ciliary arteries and nerves, which are located in the horizontal meridian. The medial, inferior, lateral, and superior rectus muscles insert progressively farther from the limbus. Locating the insertion of the inferior oblique muscle is very helpful in distinguishing between a right and a left eye (<span class="xref-figure">Fig&#160;3-1</span>). The inferior oblique inserts temporally over the macula, with its fibers running inferiorly. Once the laterality of the eye is determined, accurate location of ocular lesions is possible.</p>
			</div>
			<p class="h1 ParaOverride-6">Gross Dissection</p>
				<div id="Chapt3_Top4">
			<p class="body-text--no-indent-">Prior to gross dissection, eyes are <span class="italic">transilluminated</span> with bright light. This helps to identify intraocular lesions such as tumors, which block the transilluminated light and cast a shadow (<span class="xref-figure">Fig&#160;3-2A</span>). The shadow can be outlined with a marking pencil on the sclera (<span class="xref-figure">Fig&#160;3-2B</span>). This outline can then be used to guide the gross dissection of the globe so that the center of the section includes the maximum extent of the area of interest (<span class="xref-figure">Figs&#160;3-2C to 3-2E</span>).</p>
			<p class="body-text">The objective of gross dissection is to open the globe in such a way as to display as much of the pathologic change as possible on a single slide. The majority of eyes are cut so that the pupil and optic nerve are present in the same section, which is called the <span class="italic">pupil–optic nerve (PO) section.</span> The meridian, or clock-hour, of the section is determined by the unique features of the case, such as the presence of an intraocular tumor or a history of previous surgery or trauma. In routine cases, eyes with no prior surgery or intraocular neoplasm are typically opened in the horizontal meridian, which includes the macula in the same section as the pupil and optic nerve (<span class="xref-figure">Fig&#160;3-3</span>). Globes with a surgical or nonsurgical wound should be opened such that the wound is perpendicular to, and included in, the PO section. Globes with intraocular tumors are opened in a way (horizontal, vertical, or oblique) that places the center of the tumor, as outlined by transillumination, in the PO section (Video&#160;3-1).</p>
			<div class="_idGenObjectLayout-1">
				<div id="_idContainer001" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="data:image/jpg;base64,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" alt="" />
				</div>
			</div>
			<p class="QR-code-caption-first ParaOverride-7"><span class="QR-code-number">Video 3-1</span> Gross dissection of the eye.</p>
			<p class="QR-code-source">Courtesy of Ralph C. Eagle, Jr, MD.</p>
			<p class="QR-code-text-last ParaOverride-8">Access all Section&#160;4 videos at www.aao.org/bcscvideo_section04.</p>
			<p class="body-text">The globe can also be opened coronally with separation of the anterior and posterior segments, allowing a clinician’s view of posterior segment pathology.</p>
			</div>
			<p class="h1">Processing and Staining</p>
				<div id="Chapt3_Top5">
			<p class="h2-h1">Tissue Processing</p>
			<p class="body-text--no-indent-">The infiltration and embedding process replaces most of the water in the tissue with paraffin. The organic solvents used in this process dissolve lipids and may dissolve some synthetic materials. Routine processing usually dissolves intraocular lenses made of polymethyl methacrylate (PMMA), acrylic, or silicone. Sutures made of silk, nylon, or other synthetic materials do not dissolve during routine processing. Embedding tissue in a paraffin block mechanically stabilizes the tissue, allowing for cutting very thin sections through the tissue.</p>
			<p class="body-text">The processing of even a “routine” specimen usually takes a day. Thus, it is unreasonable for a surgeon to expect an interpretation of a specimen sent for permanent sections to be available on the same day as the biopsy. Techniques for the rapid processing of special surgical pathology material are generally reserved for biopsy specimens that require urgent handling. Because the quality of histologic preparation after rapid processing is usually inferior to that of standard processing, it should not be requested routinely. Surgeons should communicate directly with their pathologists about the availability and shortcomings of these techniques.</p>
			<p class="h2">Tissue Staining and Slide Preparation</p>
			<p class="body-text--no-indent-">Tissue sections are usually cut at 4–6&#160;µm. The cut section is colorless except for areas of indigenous pigmentation, and various tissue dyes—principally hematoxylin-&#173;eosin and periodic acid–Schiff (PAS)—are used to color the tissue for identification. A small amount of resin is placed over the stained section and covered with a thin glass coverslip to protect and preserve it. <span class="xref-table">Table&#160;3-2</span> lists the histochemical stains commonly used in ophthalmic pathology.</p>
		</div>
		</div>
		<div id="_idContainer003" class="Basic-Text-Frame">
			<table id="table001" class="Basic-Table TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-1" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-3" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-4" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-5">
						<td class="Basic-Table CellOverride-1 _idGenCellOverride-1" colspan="5">
							<p class="table-title"><span class="table-number">Table 3-1</span> Fixatives Commonly Used in Ophthalmic Pathology</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Fixative</p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Color</p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Examples of Use</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-7">
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">10% neutral-buffered formalin (NBF) </p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Clear</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Routine fixation of all tissues (eg, eyelid, conjunctiva, globe, orbital)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Bouin solution </p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Yellow</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Small biopsies (eg, gastrointestinal tissue, conjunctiva)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-9">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Absolute ethanol or methanol </p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Clear</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Crystals (eg, corneal urate crystals)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-10">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Cytology fixatives (ethanol, methanol, or Saccomanno fixative) </p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Variety of colors</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Liquid specimens or smears (eg, vitreous, aqueous, fine-needle aspirates, corneal smears)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Glutaraldehyde</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Clear</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Electron microscopy (eg, renal biopsy, corneal microsporidia)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-10">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Michel or Zeus transport medium*</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Clear </p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Immunofluorescence (eg, conjunctival biopsy for mucous membrane pemphigoid)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-11">
						<td class="Basic-Table CellOverride-6">
							<p class="table-body">Roswell Park Memorial Institute (RPMI) tissue culture medium*</p>
						</td>
						<td class="Basic-Table CellOverride-6" />
						<td class="Basic-Table CellOverride-6">
							<p class="table-body">Pink, salmon</p>
						</td>
						<td class="Basic-Table CellOverride-6" />
						<td class="Basic-Table CellOverride-6">
							<p class="table-body">Tissue culture (eg, orbital tumor for cytogenetics or flow cytometry)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-9">
						<td class="Basic-Table CellOverride-7" colspan="5">
							<p class="table-body">*Not a true fixative, but prolongs tissue decomposition.</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer006">
				<div id="_idContainer004" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="BCSC1718_S04_C03_p025_032-web-resources/image/KIN00911.png" alt="" />
				</div>
				<div id="_idContainer005" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 3-1</span> Posterior view of right globe. N&#160;= nasal, T&#160;= temporal. <span class="figure-caption-bold">A,</span>&#160;Diagram. <span class="figure-caption-bold">B,</span>&#160;Macroscopic photograph. Note that the posterior ciliary artery and nerve appear as a subtle blue-gray line as they pass through the sclera. This marks the horizontal meridian of the globe. Also note that the rectus muscle insertions are not present. The rectus muscles are typically incised at their scleral insertion during enucleation so that they may be attached to the orbital implant. <span class="figure-source-note">(Part A modified by C.H.&#160;Wooley from an illustration by Thomas&#160;A. Weingeist, PhD, MD; part&#160;B courtesy of Nasreen&#160;A. Syed, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer009">
				<div id="_idContainer007" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="BCSC1718_S04_C03_p025_032-web-resources/image/AAX-8931.png" alt="" />
				</div>
				<div id="_idContainer008" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 3-2</span> Preparation of an intraocular tumor specimen. <span class="figure-caption-bold">A,</span>&#160;Transillumination shows blockage of light due to an intraocular tumor. <span class="figure-caption-bold">B,</span>&#160;The area of blockage is marked with a marking pencil. <span class="figure-caption-bold">C,</span>&#160;The opened eye shows the intraocular tumor that was demonstrated by transillumination. <span class="figure-caption-bold">D,</span>&#160;The paraffin-&#173;embedded eye shows the intraocular tumor. <span class="figure-caption-bold">E,</span>&#160;The hematoxylin-&#173;eosin (H&amp;E)–stained section shows that the maximum extent of the tumor demonstrated by transillumination is in the center of the section, which includes the pupil and optic nerve. <span class="figure-source-note">(Part&#160;A courtesy of Nasreen&#160;A. Syed, MD; part&#160;B courtesy of Hans&#160;E. Grossniklaus, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer012">
				<div id="_idContainer010" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="BCSC1718_S04_C03_p025_032-web-resources/image/AAX-1554.png" alt="" />
				</div>
				<div id="_idContainer011" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 3-3</span> Gross dissection of a globe. <span class="figure-caption-bold">A,</span>&#160;The goal of sectioning is to obtain a pupil–optic nerve (PO) section that contains the maximum area of interest. <span class="figure-caption-bold">B,</span>&#160;Two caps, or <span class="figure-caption-italic">calottes,</span> are removed to obtain a PO section. <span class="figure-caption-bold">C,</span>&#160;The first cut is generally performed from posterior to anterior. <span class="figure-caption-bold">D,</span>&#160;The second cut yields the PO section. <span class="figure-source-note">(Illustration by Christine Gralapp.)</span></p>
				</div>
			</div>
		</div>
		<div id="_idContainer013" class="Basic-Text-Frame">
			<table id="table002" class="Basic-Table TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-12" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-13" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-14" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-5">
						<td class="Basic-Table CellOverride-1 _idGenCellOverride-1" colspan="5">
							<p class="table-title"><span class="table-number">Table 3-2</span> Stains Commonly Used in Ophthalmic Pathology</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Stain</p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Material Stained: Color</p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Examples of Use</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-7">
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Hematoxylin-eosin (H&amp;E)</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Nucleus: blue</p>
							<p class="table-body">Cytoplasm: red</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">General tissue stain (see Fig&#160;3-2E)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-10">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Periodic acid–Schiff (PAS)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Glycogen and proteoglycans: magenta</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Descemet membrane (see Fig&#160;6-26E), lens capsule, Bruch membrane, goblet cells</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Alcian blue</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Acid mucopolysaccharide: blue</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Cavernous optic atrophy (see Fig&#160;15-10B)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-9">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Alizarin red</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Calcium: red</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Band keratopathy</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-9">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Colloidal iron</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Acid mucopolysaccharide: blue</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Macular dystrophy (see Fig&#160;6-22C)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-10">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Congo red</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Amyloid: red-orange, apple green with polarized light (dichroism)</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Lattice corneal dystrophy (see Fig&#160;6-19C, D)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Crystal violet</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Amyloid: magenta (metachromasia)</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Lattice corneal dystrophy</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-9">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Fite-Faraco</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Some acid-fast organisms: red</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body"><span class="CharOverride-1">Mycobacterium leprae </span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-10">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Giemsa, Wright-Giemsa</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Some bacteria and parasites: blue</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Conjunctival <span class="CharOverride-1">Chlamydia</span> (eg, trachoma), corneal <span class="CharOverride-1">Acanthamoeba</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-15">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Gram stain for tissue (Brown and Brenn [B&amp;B], Brown and Hopps [B&amp;H])</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Gram-positive bacteria: blue</p>
							<p class="table-body">Gram-negative bacteria: red</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Bacterial infection (see Fig 6-7B)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-10">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Gomori or Grocott methenamine silver (GMS)</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Fungal elements: black</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body"><span class="CharOverride-1">Fusarium</span> (see Fig&#160;6-5B)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Masson trichrome</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Collagen: blue</p>
							<p class="table-body">Muscle: red</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Granular dystrophy (see Fig&#160;6-20C)</p>
							<p class="table-body">Red deposits</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-9">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Perls Prussian blue</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Iron: blue</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Fleischer ring</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Thioflavin T (ThT)</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Amyloid: fluorescent yellow-white</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Lattice corneal dystrophy</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Verhoeff–van Gieson (elastic) </p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Elastic fibers: black</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Temporal artery elastic layer (see Fig&#160;15-6B)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-9">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">von Kossa</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Calcium phosphate salts: black</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Band keratopathy (see Fig&#160;6-10C)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-11">
						<td class="Basic-Table CellOverride-6">
							<p class="table-body">Ziehl-Neelsen </p>
						</td>
						<td class="Basic-Table CellOverride-6" />
						<td class="Basic-Table CellOverride-6">
							<p class="table-body">Acid-fast organisms: red</p>
						</td>
						<td class="Basic-Table CellOverride-6" />
						<td class="Basic-Table CellOverride-6">
							<p class="table-body"><span class="CharOverride-1">Mycobacterium tuberculosis</span> and most other mycobacteria</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
	</body>
</html>
